RHÃN-KLINIKUM AG / Final Results/Quarter Results
28.04.2010 07:02
Dissemination of a Corporate News, transmitted by
DGAP - a company of EquityStory AG.
The issuer / publisher is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
Results for financial year 2009
* Further 9.2 % increase in patient treatments is proof of the trust in the
high quality of medical care offering
* With growth in revenues of 8.9 % and in earnings of 7.4 % in 2009, we
demonstrate the sustainability of our growth course, also in times of
crisis.
* With the capital increase of roughly EUR 460 million, we have laid the
foundation for further expanding our healthcare network.
* In 2009 we invested roughly EUR 414 million of company funds in the
expansion of our care network, demonstrating our investment capacity and
innovative strength.
Q1 2010 results
* Continued rise in patient numbers by 57,474 cases or 12.7 % to a total of
509,793 cases (previous year: 452,319 cases) underscores our good start
into the new financial year
* Revenues climbed by 11.6% to reach EUR 624.2 million
* Net consolidated profit rose by EUR 3.6 million or 11.7 % to reach EUR
34.3 million
* EBITDA rose by EUR 6.1 million or 9.1 % to reach EUR 73.1 million
* EBIT improved by EUR 4.0 million or 9.4 % to EUR 46.8 million
Forecast for the further course of 2010
The Company confirms its forecast for 2010. Despite a challenging
environment, the Company expects to generate revenues of approximately 2.6
billion euros and a net profit of roughly 145 million euros within a range
of plus/minus 5 %.
Bad Neustadt a.d. Saale/Frankfurt am Main, 28 April 2010
At its annual Results Press Conference held today in Frankfurt am Main, the
Board of Management of RHÃN-KLINIKUM AG will confirm the trend figures
already published in February. 'We once again demonstrated in 2009 that the
Company's high quality of medical care and restructuring experience make it
a reliable partner for patients, employees as well as the State', said
Wolfgang Pföhler, chairman of the Board of Management of RHÃN-KLINIKUM AG.
He stated that the healthcare network had been expanded, and that with the
capital increase the basis for new growth had been created. Pföhler will
also inform that the Board member Ralf Stähler will leave the Company for
personal reasons as of 30 April.
Results for financial year 2009
In 2009, a total of 1.8 million patients were treated in the Group's
facilities. During the same period, revenues rose to 2.3 billion euros. Net
consolidated profit increased as forecast by 7.4 % to 131.7 million euros.
Compared with last year, EBITDA was raised by 8.1 % to 284.0 million euros
and EBIT by 5.8 % to 181.0 million euros. Operating cash flow saw an
increase of 11.5 % to 238.5 million euros.
The 9.2% rise in patient treatments was 'proof of the great trust in the
quality of our work'. With growth in revenues of 8.9% and in earnings of
7.4 % in 2009, the Group moreover demonstrated the sustainability of its
growth course - also in times of crisis. Pföhler gives assurance that this
'reliable' course would also be 'steadfastly' maintained in the new
financial year.
'With the August 2009 capital increase in a gross volume of roughly 460
million euros, we have created the ideal financial basis for expanding our
healthcare network', explained Dr. Erik Hamann, CFO of RHÃN-KLINIKUM AG.
Already at the end of 2009 with the takeover of the MEDIGREIF Group, the
Company expanded its healthcare network by 5 acute hospitals and 2 medical
care centres (MVZs) in Saxony-Anhalt and Mecklenburg-West Pomerania.
On 9 June 2010, the Board of Management and the Supervisory Board will
propose a dividend of EUR 0.30 per ordinary non-par share with dividend
entitlement (DE 0007042301; 138,208,000 non-par shares). Without the
capital increase - based on the previous volume of shares in circulation -
an amount of 0.40 euros per share would thus have been distributed
(previous year: 0.35 euros).
Jobs in 2009
As at 31 December 2009, RHÃN-KLINIKUM AG employed a total of 36,882 people
in ten federal states. With the acquisition of the MEDIGREIF Group, 1,421
employees were added to the Group's hospital network. At our long-standing
facilities, 1,549 additional employees were hired. These notably include
doctors and nurses. In many regions, then, the hospitals are among the
largest employers. In north and central Hesse, for example, GieÃen and
Marburg University Hospital ranks second among private companies by number
of employees.
Q1 2010 results
The Management is pleased with the start the Company has made into
financial year 2010. 'We have got off to a solid start into the new year',
emphasises Wolfgang Pföhler.
Already in the first three months, the Group treated 509,793 patients (+
12.7 %). Revenues rose to EUR 624.2 million (+ 11.6 %). Net consolidated
profit rose 11.7% to reach EUR 34.3 million.
EBITDA climbed to EUR 73.1 million (+ 9.1 %). EBIT stood at EUR 46.8
million, which translates into a rise of 9.4% versus the previous year's
level. As at 31 March 2010, the Group had 36,915 employees.
'The good first-quarter figures provide an outstanding basis for reliably
reaching our forecast for full-year 2010', explains Dr. Erik Hamann, the
Company's CFO.
Outlook for 2010:
'High-quality medical care at reasonable costs:
strengthening co-operation models'
Board of Management chairman Pföhler emphasises that the high quality of
medical care was directly dependent on high investment capacity. 'In 2009
we invested some 332.5 million euros, thus creating the basis today for the
healthcare we will provide tomorrow. In 2011, for example, the GieÃen and
Marburg University Hospital is not only getting ready to move into
centralised, modern new buildings but also to start up operations of the
new particle therapy facility. 'We invest not only in building structures
but also in innovative medical care for people', Pföhler said. With the
particle therapy centre (PTC), Marburg was witnessing the creation of the
world's first centre making it possible to use protons and carbon ions with
great precision in the effective treatment of cancer diseases at a
completely new level. 'In Marburg we are thus establishing a leading
radiation oncology site of international standing, and in the process are
also directly and indirectly creating about 200 jobs within the region'.
Pföhler emphasises that public funding was becoming scarcer for healthcare
as well. For this reason it was important to tap into further efficiency
and rationalisation reserves, since this was the only way to ensure medical
care at a high level also in future. This also meant enabling a competition
for the best solutions in healthcare delivery. This was the only way to
free innovation. Already two years ago the RHÃN-KLINIKUM Group, with its
interfacility and cross-sector healthcare delivery approach, had developed
a model for combining medical quality and economic efficiency for patients.
RHÃN-KLINIKUM's CEO emphasises that the Company in many respects was in
good shape and highly innovative: 'Thanks to telemedicine we are able to
bring good medical care to the regions and to the patients there, who
otherwise might not at all be able to find such care at that level given
the shortage of doctors', Pföhler explaines. With our web-based electronic
patient file, the Company had created a bridge of communication for
doctors, regardless of whether they work in a hospital, an MVZ or a
doctor's practice.
'Good medical care and economic efficiency go together. This is something
we have proven in 2009. And that is our commitment also in 2010', Pföhler
concludes.
RHÃN-KLINIKUM AG is one of the largest healthcare providers in Germany. Its
corporate objective is high-quality medical care for everyone. Currently,
our Group counts 53 hospitals at 42 sites as well as 29 medical care
centres (MVZs) throughout Germany. We employ more than 36,000 persons. In
financial year 2009, roughly 1.8 million patients were treated in the
Group's facilities.
More information is available under: www.rhoen-klinikum-ag.com.
Esther Walter
Head of Group Press and Public Relations
Schlossplatz 1
97616 Bad Neustadt a. d. Saale
Tel.: 09771/ 65 - 1322
Fax: 09771/ 65 - 1820
E-Mail: esther.walter@rhoen-klinikum-ag.com
28.04.2010 07:02 Ad hoc announcement, Financial News and Media Release distributed by DGAP. Medienarchiv at |[![CDATA[|[a href="http://www.dgap-medientreff.de"|]www.dgap-medientreff.de|[/a|]]]|] and |[![CDATA[|[a href="http://www.dgap.de"|]www.dgap.de|[/a|]]]|]
---------------------------------------------------------------------------
Language: English
Company: RHÃN-KLINIKUM AG
Schlossplatz 1
97616 Bad Neustadt a.d.Saale
Deutschland
Phone: +49 (0)9771 - 65-0
Fax: +49 (0)9771 - 97 467
E-mail: rka@rhoen-klinikum-ag.com
Internet: www.rhoen-klinikum-ag.com
ISIN: DE0007042301
WKN: 704230
Indices: MDAX
Listed: Regulierter Markt in Frankfurt (Prime Standard), München;
Freiverkehr in Berlin, Düsseldorf, Hamburg, Stuttgart
End of News DGAP News-Service
---------------------------------------------------------------------------
DGAP-News: RHÃN-KLINIKUM AG: Results Press Conference in Frankfurt/Main on 28 April 2010 at 11:00 a.m.
| Quelle: EQS Group AG